Literature DB >> 21344381

Cooperative nongenomic and genomic actions on thyroid hormone mediated-modulation of T cell proliferation involve up-regulation of thyroid hormone receptor and inducible nitric oxide synthase expression.

Maria L Barreiro Arcos1, Helena A Sterle, Maria A Paulazo, Eduardo Valli, Alicia J Klecha, Blanca Isse, Claudia G Pellizas, Ricardo N Farias, Graciela A Cremaschi.   

Abstract

Thyroid hormones (THs) exert a broad range of actions on development, growth, and cell differentiation by both genomic and nongenomic mechanisms. THs regulate lymphocyte function, but the participation of nongenomic actions is still unknown. Here the contribution of both genomic and nongenomic effects on TH-induced division of T cells was studied by using free and noncell permeable THs coupled to agarose (TH-ag). THs-ag led to cell division, but to a lesser extent than free hormones. THs induced nongenomically the rapid translocation of protein kinase C (PKC) ζ isoform to cell membranes, extracellular-signal-regulated kinases (ERK1/2) phosphorylation and nuclear factor-κB (NF-κB) activation. The signaling cascade include sphingomyelinases acting up-stream the activation of PKCζ isoform, while ERK and NF-κB are activated downstream this PKC isoenzyme. Both free and THs-ag increased the protein and mRNA levels of TH nuclear receptor TRα1, while only free hormones incremented the inducible NOS gene and protein levels as well as a calcium independent NOS activity. Both effects were blunted by PKCζ inhibition. These results indicate that THs, by triggering a nongenomic signaling cascade that involves Smases-mediated activation of PKCζ, lead to ERK 1/2 and NF-κB activation and to the genomic increase of TRs and the inducible nitric oxide synthase protein and mRNA levels, improving T lymphocyte proliferation. These finding not only contribute to the understanding of the mechanisms involved in TH modulation of lymphocyte physiology, but would also point out for the first time the interplay between genomic and nongenomic TH actions in T cells.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21344381     DOI: 10.1002/jcp.22681

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Prevalence of Dio2(T92A) polymorphism and its association with thyroid autoimmunity.

Authors:  A Guerra; M R Sapio; M Carrano; V Di Stasi; A Volpe; A Murino; G Izzo; M Vitale
Journal:  J Endocrinol Invest       Date:  2012-09-24       Impact factor: 4.256

2.  Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells.

Authors:  Florencia Cayrol; María Celeste Díaz Flaqué; Tharu Fernando; Shao Ning Yang; Helena Andrea Sterle; Marcela Bolontrade; Mariana Amorós; Blanca Isse; Ricardo Norberto Farías; Haelee Ahn; Ye F Tian; Fabrizio Tabbò; Ankur Singh; Giorgio Inghirami; Leandro Cerchietti; Graciela Alicia Cremaschi
Journal:  Blood       Date:  2014-12-08       Impact factor: 22.113

3.  The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies.

Authors:  H A Sterle; M L Barreiro Arcos; E Valli; M A Paulazo; S P Méndez Huergo; A G Blidner; F Cayrol; M C Díaz Flaqué; A J Klecha; V A Medina; L Colombo; G A Rabinovich; G A Cremaschi
Journal:  J Mol Med (Berl)       Date:  2015-11-13       Impact factor: 4.599

Review 4.  Dynamic Interactions Between the Immune System and the Neuroendocrine System in Health and Disease.

Authors:  John R Klein
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-22       Impact factor: 5.555

Review 5.  The interplay of thyroid hormones and the immune system - where we stand and why we need to know about it.

Authors:  Christina Wenzek; Anita Boelen; Astrid M Westendorf; Daniel R Engel; Lars C Moeller; Dagmar Führer
Journal:  Eur J Endocrinol       Date:  2022-03-23       Impact factor: 6.558

6.  Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease.

Authors:  Keiichi Torimoto; Yosuke Okada; Shingo Nakayamada; Satoshi Kubo; Akira Kurozumi; Manabu Narisawa; Yoshiya Tanaka
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.